← Open Payments lookup

JARED NELSON: Open Payments

NPI 1295091791 · RIALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$921 in 44 payments from 8 companies in 2025. Trend: 2023 $314 · 2024 $476 · 2025 $921

Food & beverage: $921
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$259
E.R. Squibb & Sons, L.L.C.10$191
Teva Pharmaceuticals USA, Inc.6$125
Janssen Pharmaceuticals, Inc6$95
Alkermes, Inc.4$90
Otsuka America Pharmaceutical, Inc.4$86
Luye Pharma (USA) Ltd.3$47
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$28

Products named: INGREZZA, COBENFY, AUSTEDO XR, INVEGA SUSTENNA, ARISTADA, ABILIFY ASIMTUFII, ERZOFRI EXTENDED-RELEASE, CAPLYTA.

Industry payments across CA — which companies pay providers there.